Cite
HARVARD Citation
Tembhare, P. et al. (2020). A High‐Sensitivity 10‐Color Flow Cytometric Minimal Residual Disease Assay in B‐Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2‐in‐106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 Patients. Cytometry. 98 (1), pp. 57-67. [Online].